Scott Gottlieb on Food and Drug Administration Policy
Dr. Scott Gottlieb, the outgoing Food and Drug Administration commissioner, about his tenure and the future of the agency. Among the issues… read more
Dr. Scott Gottlieb, the outgoing Food and Drug Administration commissioner, about his tenure and the future of the agency. Among the issues discussed were tobacco and nicotine regulation, rules governing the development of generic drugs and biosimilars, and drug testing on animals. Dr. Gottlieb was interviewed by Bloomberg News' Anna Edney close
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and tap the screen to see the at the bottom of the player. Tap the to see a complete list of all Points of Interest - click on any moment in the list and the video will play.
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and move your cursor over the video to see the . Click on the marker to see the description and watch.
You can also click the in the lower left of the video player to see a complete list of all Points of Interest from this program - click on any moment in the list and the video will play.
People in this video
-
-
David M. Wessel Founding Director and Senior Fellow Brookings Institution->Center on Fiscal and Monetary Policy
Hosting Organization
Related Video
-
FDA Commissioner on E-Cigarettes and Public Health Concerns
Axios held an in-depth discussion on the increasing trend among teens using e-cigarettes and what policymakers are doing to address…
-
Newsmakers with Scott Gottlieb
Scott Gottlieb talked about the nation’s opioid epidemic, as well as drug prices and the Food and Drug Administration’s…
-
FDA Commissioner Gottlieb at National Press Club
FDA Commissioner Scott Gottlieb delivered the keynote remarks at a National Press Club Headliners Luncheon. He talked about the…
-
FDA Fiscal Year 2018 Budget
Commissioner Scott Gottlieb testified before a Senate Appropriations subcommittee on the President Trump’s fiscal year 2018 Food and Drug…